nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranolazine—CYP3A4—Temozolomide—malignant glioma	0.447	1	CbGbCtD
Ranolazine—Pulmonary fibrosis—Carmustine—malignant glioma	0.0212	0.0409	CcSEcCtD
Ranolazine—Pulmonary fibrosis—Temozolomide—malignant glioma	0.0205	0.0395	CcSEcCtD
Ranolazine—Altered state of consciousness—Temozolomide—malignant glioma	0.0195	0.0377	CcSEcCtD
Ranolazine—Nephropathy toxic—Carmustine—malignant glioma	0.0162	0.0313	CcSEcCtD
Ranolazine—Parosmia—Temozolomide—malignant glioma	0.0139	0.0268	CcSEcCtD
Ranolazine—Carvedilol—GJA1—malignant glioma	0.0137	0.382	CrCbGaD
Ranolazine—Carvedilol—HIF1A—malignant glioma	0.0103	0.29	CrCbGaD
Ranolazine—Gait disturbance—Carmustine—malignant glioma	0.00954	0.0184	CcSEcCtD
Ranolazine—Coordination abnormal—Carmustine—malignant glioma	0.00948	0.0183	CcSEcCtD
Ranolazine—Hearing impaired—Temozolomide—malignant glioma	0.00945	0.0183	CcSEcCtD
Ranolazine—Gait disturbance—Temozolomide—malignant glioma	0.00922	0.0178	CcSEcCtD
Ranolazine—Coordination abnormal—Temozolomide—malignant glioma	0.00916	0.0177	CcSEcCtD
Ranolazine—Depressed level of consciousness—Carmustine—malignant glioma	0.00899	0.0174	CcSEcCtD
Ranolazine—Depressed level of consciousness—Temozolomide—malignant glioma	0.00869	0.0168	CcSEcCtD
Ranolazine—Amnesia—Carmustine—malignant glioma	0.0072	0.0139	CcSEcCtD
Ranolazine—Hot flush—Temozolomide—malignant glioma	0.00698	0.0135	CcSEcCtD
Ranolazine—Amnesia—Temozolomide—malignant glioma	0.00695	0.0134	CcSEcCtD
Ranolazine—Menopausal symptoms—Temozolomide—malignant glioma	0.00692	0.0134	CcSEcCtD
Ranolazine—Diplopia—Carmustine—malignant glioma	0.00676	0.0131	CcSEcCtD
Ranolazine—Diplopia—Temozolomide—malignant glioma	0.00653	0.0126	CcSEcCtD
Ranolazine—Dehydration—Temozolomide—malignant glioma	0.00608	0.0117	CcSEcCtD
Ranolazine—Breast disorder—Temozolomide—malignant glioma	0.0059	0.0114	CcSEcCtD
Ranolazine—Pancytopenia—Carmustine—malignant glioma	0.00555	0.0107	CcSEcCtD
Ranolazine—Pancytopenia—Temozolomide—malignant glioma	0.00536	0.0104	CcSEcCtD
Ranolazine—Ropivacaine—CYP2B6—malignant glioma	0.00536	0.15	CrCbGaD
Ranolazine—Dysuria—Temozolomide—malignant glioma	0.00528	0.0102	CcSEcCtD
Ranolazine—Erectile dysfunction—Temozolomide—malignant glioma	0.0052	0.01	CcSEcCtD
Ranolazine—Renal failure—Carmustine—malignant glioma	0.00512	0.00989	CcSEcCtD
Ranolazine—Weight decreased—Temozolomide—malignant glioma	0.00511	0.00987	CcSEcCtD
Ranolazine—Hallucination—Carmustine—malignant glioma	0.00465	0.00899	CcSEcCtD
Ranolazine—Hypoaesthesia—Carmustine—malignant glioma	0.00465	0.00899	CcSEcCtD
Ranolazine—Oedema peripheral—Carmustine—malignant glioma	0.00461	0.0089	CcSEcCtD
Ranolazine—Connective tissue disorder—Carmustine—malignant glioma	0.0046	0.00888	CcSEcCtD
Ranolazine—Visual impairment—Carmustine—malignant glioma	0.00451	0.00871	CcSEcCtD
Ranolazine—Hypoaesthesia—Temozolomide—malignant glioma	0.0045	0.00869	CcSEcCtD
Ranolazine—Hallucination—Temozolomide—malignant glioma	0.0045	0.00869	CcSEcCtD
Ranolazine—Urinary tract disorder—Temozolomide—malignant glioma	0.00446	0.00862	CcSEcCtD
Ranolazine—Oedema peripheral—Temozolomide—malignant glioma	0.00445	0.0086	CcSEcCtD
Ranolazine—Connective tissue disorder—Temozolomide—malignant glioma	0.00444	0.00858	CcSEcCtD
Ranolazine—Urethral disorder—Temozolomide—malignant glioma	0.00443	0.00856	CcSEcCtD
Ranolazine—Eye disorder—Carmustine—malignant glioma	0.00437	0.00844	CcSEcCtD
Ranolazine—Visual impairment—Temozolomide—malignant glioma	0.00436	0.00841	CcSEcCtD
Ranolazine—Eye disorder—Temozolomide—malignant glioma	0.00422	0.00816	CcSEcCtD
Ranolazine—Tinnitus—Temozolomide—malignant glioma	0.00421	0.00814	CcSEcCtD
Ranolazine—Cardiac disorder—Temozolomide—malignant glioma	0.00419	0.0081	CcSEcCtD
Ranolazine—Arrhythmia—Carmustine—malignant glioma	0.00418	0.00807	CcSEcCtD
Ranolazine—Carvedilol—VEGFA—malignant glioma	0.00417	0.117	CrCbGaD
Ranolazine—Angiopathy—Temozolomide—malignant glioma	0.0041	0.00792	CcSEcCtD
Ranolazine—Mental disorder—Carmustine—malignant glioma	0.0041	0.00792	CcSEcCtD
Ranolazine—Mediastinal disorder—Temozolomide—malignant glioma	0.00407	0.00787	CcSEcCtD
Ranolazine—Malnutrition—Carmustine—malignant glioma	0.00407	0.00787	CcSEcCtD
Ranolazine—Mental disorder—Temozolomide—malignant glioma	0.00396	0.00765	CcSEcCtD
Ranolazine—Malnutrition—Temozolomide—malignant glioma	0.00393	0.0076	CcSEcCtD
Ranolazine—Vision blurred—Carmustine—malignant glioma	0.00384	0.00741	CcSEcCtD
Ranolazine—Tremor—Carmustine—malignant glioma	0.00381	0.00737	CcSEcCtD
Ranolazine—Vision blurred—Temozolomide—malignant glioma	0.00371	0.00716	CcSEcCtD
Ranolazine—Tremor—Temozolomide—malignant glioma	0.00369	0.00712	CcSEcCtD
Ranolazine—Leukopenia—Carmustine—malignant glioma	0.00364	0.00704	CcSEcCtD
Ranolazine—Angioedema—Temozolomide—malignant glioma	0.00359	0.00695	CcSEcCtD
Ranolazine—Vertigo—Temozolomide—malignant glioma	0.00353	0.00683	CcSEcCtD
Ranolazine—Leukopenia—Temozolomide—malignant glioma	0.00352	0.0068	CcSEcCtD
Ranolazine—Palpitations—Temozolomide—malignant glioma	0.00348	0.00672	CcSEcCtD
Ranolazine—Anxiety—Carmustine—malignant glioma	0.00345	0.00667	CcSEcCtD
Ranolazine—Cough—Temozolomide—malignant glioma	0.00343	0.00663	CcSEcCtD
Ranolazine—Confusional state—Carmustine—malignant glioma	0.00335	0.00647	CcSEcCtD
Ranolazine—Anxiety—Temozolomide—malignant glioma	0.00334	0.00645	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00333	0.00643	CcSEcCtD
Ranolazine—Dry mouth—Temozolomide—malignant glioma	0.00328	0.00633	CcSEcCtD
Ranolazine—Thrombocytopenia—Carmustine—malignant glioma	0.00325	0.00628	CcSEcCtD
Ranolazine—Confusional state—Temozolomide—malignant glioma	0.00324	0.00625	CcSEcCtD
Ranolazine—Anorexia—Carmustine—malignant glioma	0.00317	0.00612	CcSEcCtD
Ranolazine—Nervous system disorder—Temozolomide—malignant glioma	0.00315	0.00608	CcSEcCtD
Ranolazine—Thrombocytopenia—Temozolomide—malignant glioma	0.00314	0.00607	CcSEcCtD
Ranolazine—Skin disorder—Temozolomide—malignant glioma	0.00312	0.00603	CcSEcCtD
Ranolazine—Hypotension—Carmustine—malignant glioma	0.0031	0.006	CcSEcCtD
Ranolazine—Hyperhidrosis—Temozolomide—malignant glioma	0.0031	0.006	CcSEcCtD
Ranolazine—Anorexia—Temozolomide—malignant glioma	0.00306	0.00591	CcSEcCtD
Ranolazine—Insomnia—Carmustine—malignant glioma	0.00301	0.00581	CcSEcCtD
Ranolazine—Paraesthesia—Carmustine—malignant glioma	0.00298	0.00576	CcSEcCtD
Ranolazine—Dyspnoea—Carmustine—malignant glioma	0.00296	0.00572	CcSEcCtD
Ranolazine—Somnolence—Carmustine—malignant glioma	0.00295	0.00571	CcSEcCtD
Ranolazine—Insomnia—Temozolomide—malignant glioma	0.0029	0.00561	CcSEcCtD
Ranolazine—Decreased appetite—Carmustine—malignant glioma	0.00289	0.00558	CcSEcCtD
Ranolazine—Paraesthesia—Temozolomide—malignant glioma	0.00288	0.00557	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Carmustine—malignant glioma	0.00287	0.00554	CcSEcCtD
Ranolazine—Dyspnoea—Temozolomide—malignant glioma	0.00286	0.00553	CcSEcCtD
Ranolazine—Somnolence—Temozolomide—malignant glioma	0.00285	0.00551	CcSEcCtD
Ranolazine—Constipation—Carmustine—malignant glioma	0.00284	0.00549	CcSEcCtD
Ranolazine—Dyspepsia—Temozolomide—malignant glioma	0.00283	0.00546	CcSEcCtD
Ranolazine—Decreased appetite—Temozolomide—malignant glioma	0.00279	0.00539	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00277	0.00536	CcSEcCtD
Ranolazine—Fatigue—Temozolomide—malignant glioma	0.00277	0.00535	CcSEcCtD
Ranolazine—Constipation—Temozolomide—malignant glioma	0.00275	0.0053	CcSEcCtD
Ranolazine—Feeling abnormal—Carmustine—malignant glioma	0.00274	0.00529	CcSEcCtD
Ranolazine—Gastrointestinal pain—Carmustine—malignant glioma	0.00272	0.00525	CcSEcCtD
Ranolazine—Feeling abnormal—Temozolomide—malignant glioma	0.00265	0.00511	CcSEcCtD
Ranolazine—Abdominal pain—Carmustine—malignant glioma	0.00263	0.00507	CcSEcCtD
Ranolazine—Gastrointestinal pain—Temozolomide—malignant glioma	0.00263	0.00507	CcSEcCtD
Ranolazine—Urticaria—Temozolomide—malignant glioma	0.00255	0.00493	CcSEcCtD
Ranolazine—Abdominal pain—Temozolomide—malignant glioma	0.00254	0.0049	CcSEcCtD
Ranolazine—Asthenia—Carmustine—malignant glioma	0.00238	0.00461	CcSEcCtD
Ranolazine—Asthenia—Temozolomide—malignant glioma	0.0023	0.00445	CcSEcCtD
Ranolazine—Pruritus—Temozolomide—malignant glioma	0.00227	0.00439	CcSEcCtD
Ranolazine—Carvedilol—PTGS1—malignant glioma	0.0022	0.0616	CrCbGaD
Ranolazine—Dizziness—Carmustine—malignant glioma	0.0022	0.00424	CcSEcCtD
Ranolazine—Dizziness—Temozolomide—malignant glioma	0.00212	0.0041	CcSEcCtD
Ranolazine—Vomiting—Carmustine—malignant glioma	0.00211	0.00408	CcSEcCtD
Ranolazine—Rash—Carmustine—malignant glioma	0.00209	0.00405	CcSEcCtD
Ranolazine—Dermatitis—Carmustine—malignant glioma	0.00209	0.00404	CcSEcCtD
Ranolazine—Headache—Carmustine—malignant glioma	0.00208	0.00402	CcSEcCtD
Ranolazine—Vomiting—Temozolomide—malignant glioma	0.00204	0.00394	CcSEcCtD
Ranolazine—Rash—Temozolomide—malignant glioma	0.00202	0.00391	CcSEcCtD
Ranolazine—Dermatitis—Temozolomide—malignant glioma	0.00202	0.00391	CcSEcCtD
Ranolazine—Headache—Temozolomide—malignant glioma	0.00201	0.00389	CcSEcCtD
Ranolazine—Nausea—Carmustine—malignant glioma	0.00197	0.00381	CcSEcCtD
Ranolazine—Nausea—Temozolomide—malignant glioma	0.00191	0.00368	CcSEcCtD
